Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic model

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 7, 2001, Pages 2136-2140

  Ross, G H ^a   Wright, D H ^a   Hovde, L B ^a   Peterson, M L ^a   Rotschafer, J C ^a  

^a REGIONS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BACTEROIDES THETAIOTAOMICRON; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG EXPOSURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BACTEROIDES; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; OFLOXACIN; TIME FACTORS;

EID: 0034951214     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.7.2136-2140.2001     Document Type: Article

References (10)

1. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxaein
2. Antimicrobial resistance in fecal flora: Longitudinal community-based surveillance of children from urban Mexico
3. Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections
4. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms
5. Possible role for the new fluoroquinoloncs (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU6859a) in the treatment of anaerobic infections: Review of current information on efficacy and safety
6. High frequency of antimicrobial resistance in human fecal flora
7. Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure
8. Kinetic model for gentamicin dosing with use of individual patient parameters
9. Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography